SCHEMBL18895978

SCHEMBL18895978

CC1(C)CN(CC/C=C2\C3=CC=CNC3COc3ccc(OCCN4CCOCC4)cc32)CCC1(O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 4/20 0.47
▸ CNR1 P21554 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ GPR55 Q9Y2T6 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ NPC1 O15118 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ DRD2 P14416 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18896009 0.88 CCR1 (0.48) CCR1CHRM2CCR5
SCHEMBL12936669 0.84 CCR1 (0.49) CCR1CHRM2CCR5
SCHEMBL656521 0.80 CCR1 (0.72) CCR1CNR1CNR2GPR55FLT3
SCHEMBL656522 0.80 CCR1 (0.72) CCR1CNR1CNR2GPR55FLT3
SCHEMBL14580314 0.80 CCR1 (0.72) CCR1CNR1CNR2GPR55FLT3
SCHEMBL15478333 0.78 DRD2 (0.40) CCR1DRD2
SCHEMBL15478403 0.76 DRD2 (0.36) CCR1NPC1ALDH1A1DRD2RAB9A
SCHEMBL15478355 0.76 CCR1 (0.38) CCR1DRD2
SCHEMBL15478359 0.76 CCR1 (0.38) CCR1DRD2
SCHEMBL15478375 0.76 CCR1 (0.50) CCR1TP53TSHRDRD2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback